MedTrace Logo

Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra

NCT00636987 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 297

Last updated 2019-02-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to further evaluate the long-term safety and effectiveness of the Biocor and Biocor Supra Valves.

Conditions

  • Aortic Valve Insufficiency
  • Aortic Valve Regurgitation
  • Aortic Valve Stenosis
  • Aortic Valve Incompetence
  • Mitral Valve Insufficiency
  • Mitral Valve Regurgitation
  • Mitral Valve Stenosis
  • Mitral Valve Incompetence

Interventions

DEVICE

Biocor and Biocor Supra valves

Replacement for a diseased, damaged, malformed aortic or mitral heart valve

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Urban Lonn, MD, PhD · Abbott Medical Devices

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2015-10-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00636987 on ClinicalTrials.gov